# K093941: Clever Choice Mini Blood Glucose Monitoring System Model TD-4265

- Pathway: 510(k) (Special)
- Applicant: Taidoc Technology Corporation
- Decided: Mar 26, 2010 after 94 days
- Product code: CGA (Glucose Oxidase, Glucose)
- Device class: 2
- Regulation: 21 CFR 862.1345
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 2 generations back to K070472 (2007). 2 ancestors in all.
No later device cites it as a predicate yet.
0 of 3 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K090187: Fora G30 Blood Glucose Monitoring System, Model TD-4241, Taidoc Technology Corporation (2009) Summary page 2.

## Indications for use
The CLEVER CHOICE Mini Blood Glucose Monitoring System is intended for use in the quantitative measurement of glucose in fresh capillary whole blood from the finger and the following alternative sites: the palm, the forearm, the upper-arm, the calf and the thigh. It is intended for use by people with diabetes mellitus at home and by health care professionals in clinical settings as an aid in monitoring the effectiveness of diabetes control program. It is not intended for the diagnosis of or screening for diabetes mellitus, and is not intended for use on neonates. The alternative site testing in the above system can be used only during steady-state blood glucose conditions.

Source page: https://510kreport.com/device/K093941
Methodology: https://510kreport.com/methodology